Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Albengres

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Therapie|March 7, 2002
[The pharmacologic basis of pain treatment]J P Tillement, E Albengres
Nouvelle Revue Francaise D'Hematologie|January 1, 1979
[Possible pharmacologic significance of the binding of medication to plasma proteins]J P Tillement, E Albengres, S Urien
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1979
Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteinsJ P Tillement, E Albengres, S Urien
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1990
Current French system of post-marketing drug surveillanceE Albengres, F Gauthier, J P Tillement
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1981
Serum protein binding of valproic acid in healthy subjects and in patients with liver diseaseS Urien, E Albengres, J P Tillement
Therapie|July 1, 1982
[Human breast milk as a compartment of drug distribution]J P Tillement, E Albengres, M Lemaire
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1980
Effect of tienilic acid (Diflurex) on the binding of warfarin 14C to human plasma proteinsJ Prandota, E Albengres, J P Tillement
Therapie|May 1, 1980
[Organization and future prospects of pharmacovigilance in France (author's transl)]J P Tillement, E Albengres, A Auzas
Drug Safety|March 26, 1998
Systemic antifungal agents. Drug interactions of clinical significanceE Albengres, H Le Louët, J P Tillement
Transplantation Proceedings|August 1, 1997
Immunosuppressive drugs and pregnancy: experimental and clinical dataE Albengres, H Le Louet, J P Tillement
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Therapie|March 7, 2002
[The pharmacologic basis of pain treatment]J P Tillement, E Albengres
Nouvelle Revue Francaise D'Hematologie|January 1, 1979
[Possible pharmacologic significance of the binding of medication to plasma proteins]J P Tillement, E Albengres, S Urien
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1979
Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteinsJ P Tillement, E Albengres, S Urien
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1990
Current French system of post-marketing drug surveillanceE Albengres, F Gauthier, J P Tillement
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1981
Serum protein binding of valproic acid in healthy subjects and in patients with liver diseaseS Urien, E Albengres, J P Tillement
Therapie|July 1, 1982
[Human breast milk as a compartment of drug distribution]J P Tillement, E Albengres, M Lemaire
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1980
Effect of tienilic acid (Diflurex) on the binding of warfarin 14C to human plasma proteinsJ Prandota, E Albengres, J P Tillement
Therapie|May 1, 1980
[Organization and future prospects of pharmacovigilance in France (author's transl)]J P Tillement, E Albengres, A Auzas
Drug Safety|March 26, 1998
Systemic antifungal agents. Drug interactions of clinical significanceE Albengres, H Le Louët, J P Tillement
Transplantation Proceedings|August 1, 1997
Immunosuppressive drugs and pregnancy: experimental and clinical dataE Albengres, H Le Louet, J P Tillement
Pageof 9